Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors B20-4.1.1 and angiostatin (K1-3)

Medicine & Life Sciences

• Angiostatins 92%
• Angiogenesis Inhibitors 71%
• Autoimmune Experimental Encephalomyelitis 69%
• Spinal Cord 38%
• T-Lymphocytes 36%
• Interleukin-17 25%
• Cytokines 22%
• Interferons 21%
• Vascular Endothelial Growth Factor A 20%
• Kringles 17%
• Th17 Cells 14%
• Blood Vessels 13%
• Angiogenesis Inducing Agents 13%
• Capillary Permeability 13%
• Interleukin-4 11%
• Multiple Sclerosis 10%
• Therapeutics 9%
• Central Nervous System 8%
• Lymphocytes 8%
• Cell Proliferation 7%
• Antigens 7%
• In Vitro Techniques 5%
• Pharmaceutical Preparations 4%

Agriculture & Biology

• angiogenesis 72%
• encephalitis 71%
• T-lymphocytes 38%
• spinal cord 37%
• mice 34%
• interleukin-17 27%
• cytokines 23%
• vascular endothelial growth factors 23%
• blood vessels 20%
• interferons 19%
• sclerosis 11%
• interleukin-4 10%
• human diseases 9%
• central nervous system 8%
• cell proliferation 7%
• permeability 7%
• lymphocytes 7%
• therapeutics 6%
• antigens 6%
• drugs 5%
• cells 2%

Chemical Compounds

• Angiogenesis Inhibitor 100%
• Cord 73%
• Antigen 12%
• Permeability 11%
• Drug 7%